Literature DB >> 22306343

Suppression of the hypoxia inducible factor-1 function by redistributing the aryl hydrocarbon receptor nuclear translocator from nucleus to cytoplasm.

Yu Wang1, Yanjie Li, Depeng Wang, Yi Li, Abraham Chang, William K Chan.   

Abstract

The aryl hydrocarbon receptor nuclear translocator (ARNT) heterodimerizes with hypoxia inducible factor-1α (HIF-1α), followed by upregulation of genes that are essential for carcinogenesis. We utilized a novel peptide (Ainp1) to address whether the HIF-1α signaling could be suppressed by an ARNT-mediated mechanism. Ainp1 suppresses the HIF-1α-dependent luciferase expression in Hep3B cells and this suppression can be reversed by ARNT. Ainp1 reduces the interaction between ARNT and HIF-1α, suppresses the formation of the HIF-1 gel shift complex, and suppresses the ARNT recruitment to the vegf promoter. These effects are partly mediated by redistribution of the nuclear ARNT contents to the cytoplasm.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306343      PMCID: PMC3319868          DOI: 10.1016/j.canlet.2012.01.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  37 in total

1.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

Authors:  K L Talks; H Turley; K C Gatter; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.

Authors:  E Laughner; P Taghavi; K Chiles; P C Mahon; G L Semenza
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha.

Authors:  P Carrero; K Okamoto; P Coumailleau; S O'Brien; H Tanaka; L Poellinger
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  ERK activation upon hypoxia: involvement in HIF-1 activation.

Authors:  E Minet; T Arnould; G Michel; I Roland; D Mottet; M Raes; J Remacle; C Michiels
Journal:  FEBS Lett       Date:  2000-02-18       Impact factor: 4.124

5.  Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.

Authors:  Hanhua Huang; Jing-Yu Lai; Janet Do; Dingguo Liu; Lingna Li; Joselyn Del Rosario; Venkata R Doppalapudi; Steven Pirie-Shepherd; Nancy Levin; Curt Bradshaw; Gary Woodnutt; Rodney Lappe; Abhijit Bhat
Journal:  Clin Cancer Res       Date:  2011-01-13       Impact factor: 12.531

6.  Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia.

Authors:  H Suzuki; A Tomida; T Tsuruo
Journal:  Oncogene       Date:  2001-09-13       Impact factor: 9.867

7.  p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

Authors:  D E Richard; E Berra; E Gothié; D Roux; J Pouysségur
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

8.  The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription.

Authors:  Sara Brunnberg; Katarina Pettersson; Elin Rydin; Jason Matthews; Annika Hanberg; Ingemar Pongratz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

9.  Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.

Authors:  Jennifer S Isaacs; Yun-Jin Jung; Edward G Mimnaugh; Alfredo Martinez; Frank Cuttitta; Leonard M Neckers
Journal:  J Biol Chem       Date:  2002-06-06       Impact factor: 5.157

10.  Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.

Authors:  Annamaria Rapisarda; Badarch Uranchimeg; Olivier Sordet; Yves Pommier; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

View more
  5 in total

1.  Differential suppression of the aryl hydrocarbon receptor nuclear translocator-dependent function by an aryl hydrocarbon receptor PAS-A-derived inhibitory molecule.

Authors:  Jinghang Xie; Xin Huang; Miki S Park; Hang M Pham; William K Chan
Journal:  Biochem Pharmacol       Date:  2014-01-28       Impact factor: 5.858

2.  A cell-penetrating peptide suppresses the hypoxia inducible factor-1 function by binding to the helix-loop-helix domain of the aryl hydrocarbon receptor nuclear translocator.

Authors:  Yu Wang; John D Thompson; William K Chan
Journal:  Chem Biol Interact       Date:  2013-02-27       Impact factor: 5.192

3.  Organelle-Specific Nitric Oxide Detection in Living Cells via HaloTag Protein Labeling.

Authors:  Jianhua Wang; Yuzheng Zhao; Chao Wang; Qian Zhu; Zengmin Du; Aiguo Hu; Yi Yang
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

4.  Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.

Authors:  Sung Hoon Choi; Ae Ri Chung; Wonseok Kang; Jun Yong Park; Mi Sol Lee; Shin Won Hwang; Do Young Kim; Seung Up Kim; Sang Hoon Ahn; Seungtaek Kim; Kwang-Hyub Han
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 5.  Specific Inhibition of HIF Activity: Can Peptides Lead the Way?

Authors:  Ilias Mylonis; Georgia Chachami; George Simos
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.